Bafna Pharmaceuticals has informed that the Board Meeting scheduled to be held on May 28, 2012 has been postponed to May 30, 2012 due to unavoidable circumstances in order to approve Audited Financial Results of the Company for the year ended March 31, 2012 on Standalone Basis and also Consolidated Financial Results for the year ended March 31, 2012 and to declare dividend.
The above information is part of company’s filing submitted to the BSE.